The third slide of December 2025's ISHLT Journal Watch, reviewing the study "Outcomes of Lung Transplantation for end stage lung disease with connective tissue disease: a systematic review and meta-analysis." A more screenreader friendly version of the issue can be found at https://www.ishlt.org/docs/default-source/journal-watch/202512_journalwatch_pulm_dec2025.pdf

Continuing #pulmsky studies in December's #ISHLTJournalWatch, Muhammad Hayat-Syed of @bcmhouston.bsky.social highlights a study on the distinctions between short- and long-term outcomes for #lungtxp patients with connective tissue disease.

#transplantsky #surgerysky

Headshots of the five early career professionals involved in the September Issue of ISHLT Journal Watch: Ram Duvuru, Katharina Fetten, Kevin Koomalsingh, Daniel Laskey, and Anna Niroomand. Text: ISHLT Journal Watch September 2025 Cardiothoracic Surgery Current papers, reviewed and presented by Early Career professionals.

This month on #ISHLTJournalWatch, issue editor Kevin Koomalsingh collects reviews of recent #CardiothoracicSurgery research from #ISHLTEarlyCareer professionals. Topics include #LungTxp in patients w/lesions, #DCD #HeartTxp, and #Xenotransplantation.

#PulmSky #CardioSky #SurgerySky #TransplantSky

Last week I had the opportunity to present #QI work on #LungTxp and #CMV at the @fredhutch.bsky.social ICH ID Symposium. Thanks to the #TravelAward committee, my VUMC mentors, and those who attended the poster to learn about new efforts to improve #TxID care at Vanderbilt!

What an amazing showing by the MGH Lung Transplant program at #ISHLT2025! Proud to be contributing to Lung Transplant science with session moderation, oral presentations, posters, and connecting with colleagues from across the world
#MGH #LungTxp #Transplantsky #Pulmsky #ISHLT
@mgh-id.bsky.social

Wrapping up the final session at #ISHLT2025, we will lastly hear on outcomes in specific and complex patient populations.

Highlights from the oral session on Lung Transplant Outcomes 🫁♻️: Considerations for Specific Patient Populations 🧩!
#Transplantsky #LungTxp #Pulmsky

Next up at #ISHLT2025: Exploring DCD donors 🫀 - how we navigate uncertainty, decision making, & challenges. Discover how DCD offers a vital chance 🎲 to many patients waiting for lung transplant 🫁♻️.
#Transplantsky #LungTxp #Pulmsky

To start our final day of #ISHLT2025, we are ready to explore donor lung 🫁 allocation focusing on the present CAS era 🕰️. Highlights ✨ from the #ISHLT2025 oral session on Donor Lung Allocation with CAS and Beyond!
#Transplantsky #LungTxp #Pulmsky

Rounding out the day, with lung transplant 🫁♻️ in particular we have to fight off all sorts of infections 🦠👾🥊. Highlights ✨ from the #ISHLT2025 oral session on Treating #LungTxp Infections:
#TxID #Pulmsky #Transplantsky

Between sick patients 🤒 pre-transplant, hemodynamic support intra-OR 🔪, and bridging support after #LungTxp 🌉, ECLS and #ECMO are critical modern tools 🛠️. Very appreciative for perspectives at #ISHLT2025 on how to best plan & manage these systems for our 🫁♻️ pts as follows:
#transplantsky #pulmsky

When should we be prepping the robot 🤖 for #LungTxp 🫁♻️? The more space the better (ex: COPD or native lungs with air trapping and a larger chest cavity 💨), start simple, and more importantly learn from the experiences of our colleagues! ~ Dr. Jauregui (Vall d'Hebron)

Small ideas 💡 in the OR can lead to giant leaps 🐾 in what we provide for our lung transplant patients 🫁♻️:
Excited to learn about operative advances in #LungTxp through this Symposium at #ISHLT2025!
#Transplantsky #Transplant

With our new 🫁 now successfully transplanted ♻️, we may transition to outcomes after #LungTxp, and how different risk factors or scenarios may effect patient outcomes in the short-term and/or extending into future years 📆. Read on for a rapid fire series ✨🔥 on txp outcomes at #ISHLT2025 !

With our patients optimized for new 🫁, our focus shifts to novel ways to improve the donor 🫁 and take #LungTxp 🫁♻️ to the next level 🚀. Ready to hear at #ISHLT2025 how we emerging technology and EVLP can optimize 🫁 for edema 💦, infection 🦠, rejection ❌, and more! #TxID #Transplantsky #Pulmsky

When it comes to #LungTxp 🫁♻️, nothing is possible without determining the right transplant candidates ✅ and giving them the best chance 🎲 for success. Ready to learn on day 2 of #ISHLT2025 about how to tackle candidate selection & optimizing them for the big day! #transplantsky #pulmsky #TxID